News About the Role of the Transcription Factor REST in Neurons: From Physiology to Pathology

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2020 Jan 8

PMID 31905747

Citations 13

Authors

Jose M Garcia-Manteiga

Rosalba DAlessandro

Jacopo Meldolesi

Affiliations

Soon will be listed here.

Abstract

RE-1 silencing transcription factor (REST) (known also as NRSF) is a well-known transcription repressor whose strong decrease induces the distinction of neurons with respect to the other cells. Such distinction depends on the marked increased/decreased expression of specific genes, accompanied by parallel changes of the corresponding proteins. Many properties of REST had been identified in the past. Here we report those identified during the last 5 years. Among physiological discoveries are hundreds of genes governed directly/indirectly by REST, the mechanisms of its neuron/fibroblast conversions, and the cooperations with numerous distinct factors induced at the epigenetic level and essential for REST specific functions. New effects induced in neurons during brain diseases depend on the localization of REST, in the nucleus, where functions and toxicity occur, and in the cytoplasm. The effects of REST, including cell aggression or protection, are variable in neurodegenerative diseases in view of the distinct mechanisms of their pathology. Moreover, cooperations are among the mechanisms that govern the severity of brain cancers, glioblastomas, and medulloblastomas. Interestingly, the role in cancers is relevant also for therapeutic perspectives affecting the REST cooperations. In conclusion, part of the new REST knowledge in physiology and pathology appears promising for future developments in research and brain diseases.

Citing Articles

Neuronal Differentiation of Human Glioma Cells Induced by Parthenolide Under In Vitro Conditions.

Tang Z, Cao C, Tang W, Ye Y, Chen Z, Shen Y Biomedicines. 2024; 12(11).

PMID: 39595109 PMC: 11591755. DOI: 10.3390/biomedicines12112543.

Exploring miRNA therapies and gut microbiome-enhanced CAR-T cells: advancing frontiers in glioblastoma stem cell targeting.

Sandhanam K, Tamilanban T, Bhattacharjee B, Manasa K Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39382681 DOI: 10.1007/s00210-024-03479-9.

A multiomic atlas of the aging hippocampus reveals molecular changes in response to environmental enrichment.

Perez R, Tezanos P, Penarroya A, Gonzalez-Ramon A, Urdinguio R, Gancedo-Verdejo J Nat Commun. 2024; 15(1):5829.

PMID: 39013876 PMC: 11252340. DOI: 10.1038/s41467-024-49608-z.

Identification of Inhibitors of the Disease-Associated Protein Phosphatase Scp1 Using Antibody Mimetic Molecules.

Kobayashi T, Yamazaki K, Shinada J, Mizunuma M, Furukawa K, Chuman Y Int J Mol Sci. 2024; 25(7).

PMID: 38612548 PMC: 11011526. DOI: 10.3390/ijms25073737.

Molecular cloning of the gene promoter encoding the human Caγ/Stargazin divergent transcript (): characterization and regulation by the cAMP-PKA/CREB signaling pathway.

Munoz-Herrera D, Calderon-Rivera A, Zarco N, Corzo-Lopez A, Leyva-Leyva M, Monjaraz E Front Physiol. 2023; 14:1286808.

PMID: 38033343 PMC: 10687476. DOI: 10.3389/fphys.2023.1286808.

References

Johnson R, Richter N, Bogu G, Bhinge A, Teng S, Choo S . A genome-wide screen for genetic variants that modify the recruitment of REST to its target genes. PLoS Genet. 2012; 8(4):e1002624. PMC: 3320604. DOI: 10.1371/journal.pgen.1002624. View

Lee S, Oh Y, Lu Y, Kim W, Yoo A . MicroRNAs Overcome Cell Fate Barrier by Reducing EZH2-Controlled REST Stability during Neuronal Conversion of Human Adult Fibroblasts. Dev Cell. 2018; 46(1):73-84.e7. PMC: 6082428. DOI: 10.1016/j.devcel.2018.06.007. View

Oh Y, Mahar M, Ewan E, Leahy K, Zhao G, Cavalli V . Epigenetic regulator UHRF1 inactivates REST and growth suppressor gene expression via DNA methylation to promote axon regeneration. Proc Natl Acad Sci U S A. 2018; 115(52):E12417-E12426. PMC: 6310844. DOI: 10.1073/pnas.1812518115. View

Kim H, Denli A, Wright R, Baul T, Clemenson G, Morcos A . REST Regulates Non-Cell-Autonomous Neuronal Differentiation and Maturation of Neural Progenitor Cells via Secretogranin II. J Neurosci. 2015; 35(44):14872-84. PMC: 4635134. DOI: 10.1523/JNEUROSCI.4286-14.2015. View

Aoki H . Novel Rest functions revealed by conditional gene ablation. Med Mol Morphol. 2018; 51(3):129-138. DOI: 10.1007/s00795-018-0187-x. View

Suo H, Wang P, Tong J, Cai L, Liu J, Huang D . NRSF is an essential mediator for the neuroprotection of trichostatin A in the MPTP mouse model of Parkinson's disease. Neuropharmacology. 2015; 99:67-78. DOI: 10.1016/j.neuropharm.2015.07.015. View

Hwang J, Aromolaran K, Zukin R . The emerging field of epigenetics in neurodegeneration and neuroprotection. Nat Rev Neurosci. 2017; 18(6):347-361. PMC: 6380351. DOI: 10.1038/nrn.2017.46. View

Li C, Wang Z, Tang X, Zeng L, Fan X, Li Z . Molecular mechanisms and potential prognostic effects of REST and REST4 in glioma (Review). Mol Med Rep. 2017; 16(4):3707-3712. DOI: 10.3892/mmr.2017.7071. View

Hwang J, Zukin R . REST, a master transcriptional regulator in neurodegenerative disease. Curr Opin Neurobiol. 2018; 48:193-200. PMC: 5892838. DOI: 10.1016/j.conb.2017.12.008. View

10.

Song Z, Zhao D, Zhao H, Yang L . NRSF: an angel or a devil in neurogenesis and neurological diseases. J Mol Neurosci. 2014; 56(1):131-44. DOI: 10.1007/s12031-014-0474-5. View

11.

Mukherjee S, Brulet R, Zhang L, Hsieh J . REST regulation of gene networks in adult neural stem cells. Nat Commun. 2016; 7:13360. PMC: 5103073. DOI: 10.1038/ncomms13360. View

12.

Wang J, Lin X, Wang S, Wang C, Wang Q, Duan X . PHF8 and REST/NRSF co-occupy gene promoters to regulate proximal gene expression. Sci Rep. 2014; 4:5008. PMC: 4031473. DOI: 10.1038/srep05008. View

13.

Nakano Y, Kelly M, Rehman A, Boger E, Morell R, Kelley M . Defects in the Alternative Splicing-Dependent Regulation of REST Cause Deafness. Cell. 2018; 174(3):536-548.e21. PMC: 6370011. DOI: 10.1016/j.cell.2018.06.004. View

14.

Tamminga C, Zukin R . Schizophrenia: Evidence implicating hippocampal GluN2B protein and REST epigenetics in psychosis pathophysiology. Neuroscience. 2015; 309:233-42. PMC: 5550101. DOI: 10.1016/j.neuroscience.2015.07.038. View

15.

Ballas N, Mandel G . The many faces of REST oversee epigenetic programming of neuronal genes. Curr Opin Neurobiol. 2005; 15(5):500-6. DOI: 10.1016/j.conb.2005.08.015. View

16.

Song Z, Yang W, Zhou X, Yang L, Zhao D . Lithium alleviates neurotoxic prion peptide-induced synaptic damage and neuronal death partially by the upregulation of nuclear target REST and the restoration of Wnt signaling. Neuropharmacology. 2017; 123:332-348. DOI: 10.1016/j.neuropharm.2017.05.021. View

17.

Singh-Taylor A, Molet J, Jiang S, Korosi A, Bolton J, Noam Y . NRSF-dependent epigenetic mechanisms contribute to programming of stress-sensitive neurons by neonatal experience, promoting resilience. Mol Psychiatry. 2017; 23(3):648-657. PMC: 5503824. DOI: 10.1038/mp.2016.240. View

18.

Kawamura M, Sato S, Matsumoto G, Fukuda T, Shiba-Fukushima K, Noda S . Loss of nuclear REST/NRSF in aged-dopaminergic neurons in Parkinson's disease patients. Neurosci Lett. 2019; 699:59-63. DOI: 10.1016/j.neulet.2019.01.042. View

19.

Lee N, Park S, Haddad G, Kim D, Park S, Park S . Interactomic analysis of REST/NRSF and implications of its functional links with the transcription suppressor TRIM28 during neuronal differentiation. Sci Rep. 2016; 6:39049. PMC: 5157023. DOI: 10.1038/srep39049. View

20.

Ashton N, Hye A, Leckey C, Jones A, Gardner A, Elliott C . Plasma REST: a novel candidate biomarker of Alzheimer's disease is modified by psychological intervention in an at-risk population. Transl Psychiatry. 2017; 7(6):e1148. PMC: 5537638. DOI: 10.1038/tp.2017.113. View